Kotak Healthcare Fund

All Cap

Equity

Health Care

India Super Value

Others

Aggressive growth Investor Profile

Investor Profile

1–7 yearsInvestment Horizon

HNI, UHNI, Retail Investor, Mass AffluentTarget Segments

SEBI registered equity mutual fund suitable for all investor categoriesRegulatory Fit

Kotak Healthcare Fund Growth focuses on Indian healthcare and pharma companies for steady growth.

What This Strategy Does

Kotak Healthcare Reg Gr is an equity fund which captures India's ₹2.5 trillion healthcare opportunity through a concentrated portfolio, deploying capital across pharmaceuticals and medical devices to achieve broad-based earnings growth.

CW Expert Research Notes

Resilient Outperformance

The fund has demonstrated consistent outperformance against its healthcare benchmark, delivering excess returns in 1 out of the past 12 years.

Concentrated Healthcare Exposure

The strategy's differentiated approach involves a concentrated portfolio with 93.76% allocation to the healthcare sector, expressing conviction in select pharmaceutical and biotech companies.

Moderate Risk Profile

With a beta of 1.06 and volatility of 18.59%, the fund exhibits a moderate risk profile suitable for investors seeking healthcare exposure with controlled downside risk.

Performance and Risk Analysis

Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.

Fund Performance

4.9% AnnuallyAlpha

+0.0% vs +0.0% benchmarkSince Inception

+0.0% vs +0.0% benchmark3Y Annualized

+0.0% vs +0.0% benchmark5Y Annualized

Kotak Healthcare Fund

Benchmark Index

Benchmark Performance Comparison

Kotak Healthcare Fund

NIFTY 50

Risk Profile

Standard Deviation16.0%

Sharpe Ratio0.63

Beta1.04

Upside Capture95%

Detailed Risks

Market Risk

Potential demand contraction in healthcare sector due to economic slowdown could undermine earnings.

Liquidity Risk

High mid-cap exposure could amplify liquidity stress during volatility spikes, impacting rebalancing.

Concentration Risk

Concentrated healthcare sector exposure leaves fund vulnerable to regulatory pricing pressures.

Specific Strategy Risk

Competitive dynamics or supply chain disruptions could impair earnings delivery for key holdings.

Strategy Details

A closer look at the investment thesis, portfolio construction, and current holdings.

Core Investment Theme

Provides concentrated exposure to India's rapidly growing healthcare sector—companies at the forefront of delivering affordable, quality care to a vast underserved population. This high-growth theme captures powerful demographic tailwinds as rising incomes drive increased healthcare spending.

Broader Market View

Market Outlook

The equity markets appear to be in the early stages of a recovery phase following a valuation correction. Consumption trends and earnings normalization in sectors like consumer discretionary and technology suggest an attractive entry point. However, risks such as margin pressures and cyclicality warrant a balanced approach.

Why This Strategy is Attractive Now

This strategy's exposure to market leaders across consumer, financial, and technology sectors, coupled with its diversification across around 70 holdings, positions it well for the current environment. The moderate beta and balanced mix of growth and defensive names could offer risk-adjusted participation in the recovery.

Investment Style & Process

Investment Style

The portfolio exhibits characteristics of a Quality Growth strategy, emphasizing companies with durable competitive advantages, consistent earnings growth, and reasonable valuations.

Why it Makes Sense

In the current environment of moderating economic growth and elevated uncertainty, a Quality Growth approach offers exposure to resilient businesses with pricing power and sustainable growth trajectories.

High-Level Investment Process

Sourcing: The strategy appears to source investment ideas from across the market capitalization spectrum, with a focus on companies demonstrating strong fundamentals, healthy balance sheets, and attractive growth prospects. Selection: The selection process suggests a preference for businesses with defendable market positions, robust cash flow generation, and attractive returns on invested capital relative to their cost of capital. Construction: Portfolio construction is consistent with a diversified, conviction-weighted approach, balancing risk management with the pursuit of alpha through active stock selection.

Portfolio Holdings Overview

SectoralAllocation

Services95.35%

Capital Goods4.65%

Geographic Allocation

Domestic100%

Top Stock Holdings

CompanySectorAllocation

Sun Pharmaceuticals Industries LtdServices14.04%

J.B. Chemicals & Pharmaceuticals LtdServices6.63%

Max Healthcare Institute Ltd Ordinary SharesServices6.31%

Divi's Laboratories LtdServices5.90%

Fortis Healthcare LtdServices4.84%

Acutaas Chemicals LtdCapital Goods4.60%

Cipla LtdServices4.22%

Park Medi World LtdServices3.79%

Krishna Institute of Medical Sciences LtdServices3.56%

Apollo Hospitals Enterprise LtdServices3.08%

Fund House Management

The asset management company’s track record, AUM scale, and fund manager credentials.

Fund Manager Track Record

Dhananjay Tikariha

Dhananjay Tikariha has experience of 2 years. Manages 12 funds at Kotak Mahindra Asset Management Co Ltd with an AUM of approximately ₹482 Cr

25 years

Combined Team Experience

₹ 78,973 Cr

Assets Under Management

Abhishek Bisen

Co-Portfolio Manager

Mr. Abhishek Bisen has experience of 22 years. Manages 425 funds at Kotak Mahindra Asset Management Co Ltd with an AUM of approximately ₹78,491 Cr Holds a M.B.A. degree.

CW Expert Take

Kotak brings banking-grade risk assessment to fund management. Their strength is in identifying mispriced opportunities while maintaining portfolio quality. The equity teams focus on sustainable business models, while their debt strategies emphasize credit selection and liquidity management—reflecting the parent group's risk culture.

Firm Overview

Total AUM₹5,80,249.31 Cr

Investment Philosophy & Approach

Focused Expertise

Kotak AMC leverages deep healthcare sector expertise for portfolio construction.

Disciplined Approach

Rigorous bottom-up research underpins Kotak's investment process and risk management.

Long-Term Mindset

Kotak maintains a patient capital allocation approach aligned with healthcare's structural growth.

Operational & Regulatory Details

What it costs to invest, transaction mechanics, and regulatory disclosures you should know.

Costs and Fees

Total Expense Ratio (TER)2.45%

Exit Load1

Regulatory & Tax Information

INF174KA1PW4

ISIN

DailyDealing Frequency

BSE Healthcare PR INRBenchmark

LTCG | >1Year 12.5%% on gain above 1.25 Lakh

STCG | <1Year 20%%

Tax Implications (India)